Sign up
Quantellect · Analysts · Analyst Profile

Mike Kratky

Leerink Partners · Equity Research Analyst

Analyst rating accuracy & track record

Mike Kratky does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ISRGIntuitive Surgical Inc
Buy$600.00Oct 2025−44.7%Hit
ISRGIntuitive Surgical Inc
Buy$600.00Oct 2025−44.7%Hit
PODDInsulet Corporation
Buy$355.00Oct 2025−80.2%Miss
MDTMedtronic PLC
Buy$114.00Oct 2025−22.7%Miss
CRCCalifornia Resources Corp
Buy—Oct 2025−43.9%—
PRCTProcept Biorobotics Corp
Buy$65.00Oct 2025−71.2%Miss
DXCMDexCom Inc
Buy$84.00Oct 2025+4.6%Hit
TNDMTandem Diabetes Care Inc
Buy$29.00Oct 2025−14.5%Hit
VCELVericel Corp Ord
Buy$48.00Oct 2025−3.2%Hit
BBNXBeta Bionics, Inc. Common Stock
Buy$28.00Sep 2025−58.0%Hit
BBNXBeta Bionics, Inc. Common Stock
Buy$28.00Sep 2025−58.0%Hit
AXGNAxogen Inc
Buy$22.00Aug 2025+178.5%Hit
NPCENeuropace Inc
Buy$18.00Aug 2025+33.4%Hit
BBNXBeta Bionics, Inc. Common Stock
Buy$28.00Feb 2025−38.0%Hit
Prev1Next
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.